Bristol-Myers Squibb
BMY
$79.24
Share price
0.13%
Change (1 day)
39.48%
Change (1 year)
Categories
Revenue for Bristol-Myers Squibb (BMY)
Revenue in 2022 (TTM): $45.99 B
According to Bristol-Myers Squibb's latest financial reports the company's current revenue (TTM) is $45.99 B. In 2021 the company made a revenue of $45.91 B an increase over the years 2020 revenue that were of $42.22 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Bristol-Myers Squibb from 2001 to 2022
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2022 (TTM) | $45.99 B | 0.19% |
| 2021 | $45.91 B | 8.74% |
| 2020 | $42.22 B | 61.48% |
| 2019 | $26.14 B | 15.89% |
| 2018 | $22.56 B | 8.59% |
| 2017 | $20.77 B | 6.94% |
| 2016 | $19.42 B | 17.31% |
| 2015 | $16.56 B | 4.29% |
| 2014 | $15.87 B | -3.09% |
| 2013 | $16.38 B | -7.01% |
| 2012 | $17.62 B | -17.05% |
| 2011 | $21.24 B | 9.03% |
| 2010 | $19.48 B | 3.59% |
| 2009 | $18.80 B | -9.95% |
| 2008 | $20.88 B | 7.95% |
| 2007 | $19.34 B | 8% |
| 2006 | $17.91 B | -6.73% |
| 2005 | $19.20 B | -0.89% |
| 2004 | $19.38 B | -7.25% |
| 2003 | $20.89 B | 19.63% |
| 2002 | $17.46 B | -10.08% |
| 2001 | $19.42 B |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $96.04 B | 108.80% | 🇺🇸 USA |
 Novartis NVS | $51.08 B | 11.06% | 🇨🇭 Switzerland |
 Pfizer PFE | $99.67 B | 116.71% | 🇺🇸 USA |
 AbbVie ABBV | $57.81 B | 25.70% | 🇺🇸 USA |
 Eli Lilly LLY | $29.23 B | -36.43% | 🇺🇸 USA |
 Amgen AMGN | $24.52 B | -46.69% | 🇺🇸 USA |
 Sanofi SNY | $44.95 B | -2.27% | 🇫🇷 France |
 Biogen BIIB | $9.94 B | -78.38% | 🇺🇸 USA |
 Merck MRK | $58.97 B | 28.22% | 🇺🇸 USA |
 Astrazeneca AZN | $44.03 B | -4.26% | 🇬🇧 UK |